仁和药业第三季度扣非净利润增长37.16%

Core Insights - Renhe Pharmaceutical reported a revenue of 2.833 billion yuan for the first three quarters of 2025, a year-on-year decrease of 10.07% [1] - The net profit for the same period was 379 million yuan, down 8.79% year-on-year, while the net profit excluding non-recurring items was 277 million yuan, a decline of 8.59% [1] - In the third quarter, the company achieved a revenue of 858 million yuan, representing a year-on-year increase of 9.16%, with net profit rising to 88.71 million yuan, up 13% [1] - The net profit excluding non-recurring items in the third quarter was 70.15 million yuan, showing a significant increase of 37.16% year-on-year [1] Financial Performance - For the first three quarters, the company's sales expenses amounted to 263 million yuan, a reduction of 26.79% compared to 360 million yuan in the previous year, primarily due to decreases in salary and advertising expenses [1]